Patents by Inventor Thomas Kempe

Thomas Kempe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200236210
    Abstract: A data retrieval and storage system configured to provide access to data on a cellular phone during periods of inoperable communication with a cellular data network. The software application of the present invention is configured to provide monitoring of the data connection between the cellular phone and a data network. As a user receives new data files by way of example but not limitation, voice data files, text data files and data from data sources, the present invention will store the data onto the local memory of the cellular phone. The software application determines if a data file has been accessed by a user. If a user has not accessed the data file a copy thereof is maintained on the memory of the cellular phone so as to provide access thereto during time periods wherein the cellular phone is not communicably coupled to a data network.
    Type: Application
    Filed: January 17, 2019
    Publication date: July 23, 2020
    Inventor: Heiko Thomas Kempe
  • Publication number: 20070003561
    Abstract: The present invention relates to a binding member comprising at least one binding domain capable of specifically binding Streptococcus pneumoniae surface adhesion A (PsaA) protein, in particular to a binding member having at least two binding domains, to the use of said binding members in diagnostic methods as well as for treatment. In a preferred embodiment the binding member is an antibody, such as a human antibody, or a fragment thereof, and it may also be a bispecific antibody.
    Type: Application
    Filed: July 8, 2004
    Publication date: January 4, 2007
    Inventors: Anders Sorensen, Thomas Benfield, Jens Lundgren, Thomas Kempe
  • Publication number: 20050266008
    Abstract: The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to IRTA-5 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for detecting IRTA-5, as well as methods for treating various B cell malignancies, including non-Hodgkin's lymphoma.
    Type: Application
    Filed: March 28, 2005
    Publication date: December 1, 2005
    Applicant: Medarex, Inc.
    Inventors: Robert Graziano, Josephine Cardarelli, Thomas Kempe, Beth Cutter, Mohan Srinivasan